Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients: One-year clinical and eight-month angiographic outcomes from the FIREMAN registry

Chinese Medical Journal

Volumn 124, Issue 6, 2011, Pages 817-824

  Li, Yan ^a   Li, Cheng Xiang ^a   Wang, Hai Chang ^a   Xu, Bo ^b   Fang, Wei Yi ^c   Ge, Jun Bo ^d   Wang, Wei Mn ^e   Qiao, Shu Bin ^b   Chen, Jack P ^f   Shen, Wen Kuang ^g   Jiang, Hong ^h   Cong, Hong Liang ⁱ   Pu, Xiao Qun ^j   Qin, Yong Wen ^k   Jin, Hui Gen ^l   Cao, Yu ^m   Huang, He ⁿ  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FUWAI HOSPITAL   (China)

^c SHANGHAI CHEST HOSPITAL   (China)

^d ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^e PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^f NORTHSIDE HOSPITAL   (United States)

^g MAYO CLINIC   (United States)

^h WUHAN UNIVERSITY   (China)

ⁱ TIANJIN CHEST HOSPITAL   (China)

^j CENTRAL SOUTH UNIVERSITY   (China)

^k SECOND MILITARY MEDICAL UNIVERSITY   (China)

^l Putuo Districit Central Hospital   (China)

^m CENTRAL SOUTH UNIVERSITY   (China)

ⁿ Xiangtan Central Hospital   (China)

more..

Author keywords

Clinical outcomes; Coronary artery disease; Off label use; Sirolimus eluting stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; RAPAMYCIN;

ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING TIME; CHINESE; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE REGISTRY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; EVENT FREE SURVIVAL; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; SILENT MYOCARDIAL ISCHEMIA; STABLE ANGINA PECTORIS; TREATMENT INDICATION; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 79952838549     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.06.004     Document Type: Article

References (20)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
4. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005; 294: 1215-1223.
5. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591.
6. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-1019.
7. Liu HB, Xu B, Gao RL, Yang YJ, Yao M, Qin XW, et al. Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry. Chin Med J 2006; 119: 609-611.
8. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029.
9. Rao SV, Shaw RE, Brindis RG, Klein LW, Weintraub WS, Peterson ED. On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry (NCDR)). Am J Cardiol 2006; 97: 1478-1481.
10. Roy P, Buch AN, Javaid A, Okabe T, Raya V, Pinto Slottow TL, et al. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Am J Cardiol 2008; 101: 293-299.
11. Tamburino C, Di Salvo ME, Capodanno D, Marzocchi A, Sheiban I, Margheri M, et al. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. Eur Heart J 2009; 30: 1171-1179.
12. De Felice F, Fiorilli R, Parma A, Menichelli M, Nazzaro MS, Pucci E, et al. Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents. Int J Cardiol 2009; 132: 337-341.
13. Jabara R, Gradman M, Chen JP, King Iii SB, Gadesam R, Chronos NA. Clinical and angiographic features of small vessel stenting in the drug-eluting stent era. Clin Cardiol 2009; 32: E39-E44.
14. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297: 2001-2009.
15. Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med 2000; 342: 1573-1580.
16. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206.
17. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
18. Qasim A, Cosgrave J, Latib A, Colombo A. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. Am J Cardiol 2007; 100: 1619-1624.
19. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-168.
20. Iakovou I, Mehran R, Dangas G. Thrombosis after implantation of drug-eluting stents. Hellenic J Cardiol 2006; 47: 31-38.